N@N

Market Maker Surveillance Report. ETAK, CBAK, CMED, BVTI, BLDP, BSDM, Losing Stocks With Lowest Price Friction For Tuesday, No

^{Published on 2010-11-30 19:00:12, Last Modified on 2010-12-22 19:34:04 - WOPRAI}
 

November 30, 2010 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 1113 companies with "abnormal" market making, 783 companies with positive Friction Factors and 1401 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. ELEPHANT TALK COMMUNICATIONS (OTCBB:ETAK), CHINA BAK BATTERY INC (NASDAQ:CBAK), CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED), BIOVEST INTERNATIONAL INC (OTC:BVTI), BALLARD POWER SYSTEMS INC (NASDAQ:BLDP), BSD MEDICAL CORP (NASDAQ:BSDM). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     ETAK       $-0.300      -9.09%       109,030         40.35%       161,151         59.65%       -52,121         -1,737  
     CBAK       $-0.260      -12.15%      401,717         41.36%       569,457         58.64%       -167,740        -6,452  
     CMED       $-1.970      -14.53%      612,710         43.43%       767,878         54.43%       -155,168        -788    
     BVTI       $-0.140      -11.02%      99,799          38.46%       143,791         55.42%       -43,992         -3,142  
     BLDP       $-0.160      -10.88%      236,352         39.52%       361,252         60.40%       -124,900        -7,806  
     BSDM       $-0.550      -11.51%      1,219,195       46.96%       1,376,949       53.04%       -157,754        -2,868  

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows BSDM with a dollar loss Tuesday of $-0.55000 and a Friction Factor of -2,868 shares. That means that it only took 2,868 more shares of selling than buying to move BSDM lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

ELEPHANT TALK COMMUNICATIONS (OTCBB:ETAK) - Elephant Talk Communications, Inc. operates as a telecom and multimedia content distributor specializing in carrier grade mobile enabling platforms. It also offers international mobile and fixed telecom services to its telecommunications customers. The company provides traditional telecom services, media streaming, and distribution services primarily to the business-to-business community within the telecommunications market. It offers various parts of the back office network including, messaging platforms, data platforms, and billing solutions, as well as mobile virtual network enabler platforms. In addition, Elephant Talk Communications provides a range of products and services based on the integration of telecom, VoIP, SMS, FAX, conferencing, and streaming services integrated with a customer relationship management and billing application. It has a joint venture agreement with ValidSoft Ltd. The company is based in Schiphol, the Netherlands.

CHINA BAK BATTERY INC (NASDAQ:CBAK) - China BAK Battery, Inc. engages in the manufacture, commercialization, and distribution of various standard and customized lithium ion rechargeable batteries. The company offers various products, such as aluminum-case prismatic, cylindrical lithium-ion, high-power lithium-phosphate, and lithium polymer cells. Its products are used to power various applications comprising cellular phones; notebook computers; portable consumer electronics, such as digital cameras, portable media players, portable gaming devices, and personal digital assistants; and other applications, including cordless power tools, mining lamps, light electric vehicles, and hybrid electric vehicles. China BAK Battery sells its products to battery pack manufacturers, original equipment manufactures, and replacement battery manufacturers primarily in the Peoples Republic of China, Taiwan, India, the United States, and Hong Kong. The company was formerly known as Medina Coffee, Inc. and changed its name to China BAK Battery, Inc. in February 2005. China BAK Battery, Inc. was founded in 2001 and is based in Shenzhen, the Peoples Republic of China.

CHINA MEDICAL TECH-SPON ADR (NASDAQ:CMED) - China Medical Technologies, Inc., a medical device company, develops, manufactures, and markets advanced immunodiagnostic and molecular diagnostic products primarily in the Peoples Republic of China. The company offers IVD products, which utilize ECLIA technology, fluorescent in situ hybridization (FISH) technology, and surface plasmon resonance (SPR) technology to detect and monitor various diseases and disorders through the laboratory evaluation and analysis of blood, urine, or other body fluids. It offers ECLIA system, which includes ECLIA analyzer for detecting the minute levels of light triggered by combining reagents with body fluid samples to produce diagnostic results; and reagent kits for detecting and monitoring various types of diseases and disorders, including thyroid disorders, diabetes, hepatitis, SARS, Down syndrome, liver fibrosis, disorders related to reproduction and growth, and various types of tumors. The company also provides FISH imaging analysis system that enables medical practitioners to visualize and locate DNA sequences in human cells for identifying chromosomal abnormalities, using FISH technology; and offers FISH probes used for prenatal and cancer management. The FISH probes are used for the detection and monitoring the course of bladder cancer; treatment of breast cancer; prediction and diagnosis of cervical cancer; diagnosis and prognosis of various leukemias and multiple myeloma; detection of epidermal growth factor receptor abnormalities; detection of Trisomy 21, Trisomy 18, Trisomy 13, Turner syndrome, Trisomy X, XYY syndrome, DiGeorge syndrome, and triploidy; and diagnosis of prostate cancer. In addition, it offers HPV-DNA chips and SPR-based analysis system for the diagnosis of human papillomavirus (HPV) infection and genotyping of HPV. The company sells its products through distributors. China Medical Technologies, Inc. was founded in 1999 and is based in Beijing, the Peoples Republic of China.

BIOVEST INTERNATIONAL INC (OTC:BVTI) - Biovest International, Inc., a biotechnology company, develops therapeutic anti-cancer vaccine for the treatment of low-grade Follicular Lymphoma in the United States. It develops BiovaxID, a Phase III clinical trial product, which is an injectable patient-specific vaccine to treat the follicular form of non-Hodgkins lymphoma. The company develops, manufactures, and markets cell culture systems, equipment, and consumable parts to pharmaceutical, diagnostic, and biotechnology companies, as well as to research institutions worldwide. Biovest International also produces mammalian and insect cells, monoclonal antibodies, recombinant and secreted proteins, and other cell culture products using hollow fiber perfusion. It is also developing an automated cell culture instrument, AutovaxID that enables production of personalized cell-based treatments. In addition, the company sells hollow fiber bioreactors, cultureware, tubing sets, and other disposable products and supplies. Further, Biovest International engages in the production and contract manufacture of biologic drugs and cell production for research institutions. Its customers include biopharmaceutical and biotech companies, medical schools, universities, research facilities, hospitals, and public and private laboratories. The company was incorporated in 1981 as Endotronics, Inc. and changed its name to Cellex Biosciences, Inc. in 1993. Further, it changed its name to Biovest International, Inc. in 2001. The company is based in Tampa, Florida. Biovest International, Inc. is a subsidiary of Accentia Biopharmaceuticals, Inc. On November 10, 2008, Biovest International Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida, Tampa, in joint administration with Accentia Biopharmaceuticals, Inc.

BALLARD POWER SYSTEMS INC (NASDAQ:BLDP) - Ballard Power Systems Inc. engages in the design, development, manufacture, sale, and service of fuel cell products for motive and stationary power markets primarily in the United States, Canada, Japan, and Germany. It operates in three segments: Fuel Cell Products, Contract Automotive, and Material Products. The Fuel Cell Products segment provides fuel cell products and services for material handling and bus, back-up power, supplemental power, and distributed generation applications. The Contract Automotive segment engages in contract manufacturing light-duty automotive fuel cell products, as well as offers testing and engineering services. The Material Products segment provides carbon fiber material products principally for automotive applications and gas diffusion layer material for fuel cell products. Ballard Power Systems Inc. has strategic alliances with Daimler AG and Ford Motor Company to develop and commercialize automotive fuel cells; and Ebara Corporation to develop and commercialize residential cogeneration systems. The company was founded in 1979 and is headquartered in Burnaby, Canada.

BSD MEDICAL CORP (NASDAQ:BSDM) - BSD Medical Corporation develops, manufactures, markets, and services medical systems that deliver precision-focused radio frequency (RF) or microwave energy into diseased sites of the body, heating them to specified temperatures as required by a variety of medical therapies. The company develops technology and products for thermal ablation and hyperthermia cancer therapy through various techniques, which include thermal ablation that ablates soft tissues at high temperatures through focused microwave energy; superficial hyperthermia, which non-invasively treats cancerous tumors located within a few centimeters of the surface of the body, such as melanoma and recurrent breast cancer; internal or interstitial hyperthermia that treats tumors in combination with internal radiation therapy by inserting tiny microwave antennae that deliver hyperthermic microwave energy to tumors through the same catheters used to deliver radioactive materials to tumors for radiation therapy; and deep hyperthermia, which non-invasively treats tumors located deep within the body, including various problematic cancer sites located in the pelvis. It offers MicroThermX-100 microwave ablation system for ablation of soft tissue; MicroThermX-180 microwave ablation system that provides minimally invasive access to the target tissue, and could be used in open surgical, as well as in percutaneous ablation procedures; BSD-500 systems to deliver either superficial or interstitial hyperthermia therapy or both; and BSD-2000 family of products that non-invasively deliver localized therapeutic heating to solid tumors by applying RF energy to certain cancerous tumors, as well as BSD-2000/3D and BSD-2000/3D/MR. The company serves clinics, hospitals, and institutes that treat cancer in the United States and internationally. BSD Medical Corporation was founded in 1978 and is based in Salt Lake City, Utah.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net